Vine Ventures

Lykos Therapeutics is a biopharmaceutical company dedicated to transforming mental health treatment. With over three decades of experience exploring therapies assisted by psychedelics, they focus on rigorous scientific research to develop innovative medicines and therapeutic techniques for mental health disorders. Their mission is to revolutionize current practices by creating novel treatment alternatives and integrating these into the healthcare system.

SpaceVision leverages AI to analyze offline customer engagement, offering targeted marketing strategies for advertisers and retailers.

Tripp Inc. is a company focused on developing a digital psychedelic wellness platform that utilizes virtual and augmented reality to enhance emotional well-being. Founded in 2016 and headquartered in Los Angeles, California, with a satellite office in Chicago, the company creates immersive experiences that combine audio, visual elements, and gameplay mechanics to promote mindfulness and transformation. Tripp’s offerings are informed by scientific research indicating that interactive digital experiences can positively influence brain function. Through its platform, the company delivers wellness solutions designed to help users manage their emotions, reduce stress and anxiety, and achieve a state of calm and focus.

Essor is a business that specializes in helping third-party seller brands from various marketplaces achieve global scale growth. It focuses on tasks such as acquisitions, investments, sourcing, and marketing. Essor's portfolio includes rapidly growing health and wellness, and lifestyle brands like Boka, ZitSticka, and Puracy, which are sold on platforms like Amazon, through direct-to-consumer channels, and in national retailers like Target and CVS. The company leverages technology, industry expertise, and strategic collaborations to transform these 'challenger' brands into globally recognized, omnichannel brands, ultimately delivering better value to customers and stakeholders.

Clerkenwell Health is a pioneering mental health company focused on providing clinical research support services and psychedelic-assisted therapies. It specializes in offering independent, psychedelic-specialist contract research organization (CRO) services that aim to accelerate the adoption of innovative treatments across Europe. The company is dedicated to patient-centered clinical trial design and adheres to high standards in therapy protocols. Clerkenwell Health's clinic offers a structured multi-session psilocybin-assisted therapy program, which includes preparation, treatment sessions, and follow-up care provided by experienced psychotherapists. This approach not only enhances patient care but also generates robust, clinically validated data to demonstrate the efficacy of psilocybin-assisted therapy compared to traditional treatment options.

Span Health Limited, founded in 2018 and based in London, is a digital care provider focused on improving health outcomes through innovative technology. The company offers a mobile application that facilitates health and fitness tracking, enabling users to monitor their health data and reverse conditions such as diabetes, hyperinsulinemia, and other lifestyle-induced diseases. Span's services include support from healthcare professionals, such as doctors and nutritionists, to guide users in making informed dietary choices that enhance metabolic health and alleviate symptoms associated with conditions like polycystic ovary syndrome, fatty liver disease, and irritable bowel syndrome. By combining technology with personalized care, Span aims to help individuals reduce body fat, manage blood sugar levels, and improve overall well-being.